COMMUNIQUÉS West-GlobeNewswire

Capital Increase in Genmab as a Result of Employee Warrant Exercise
18/06/2024
Company Announcement COPENHAGEN, Denmark; June 18, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,986 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to Women Undergoing Breast Cancer Treatment
18/06/2024
Breast cancer patients in Switzerland will receive access to a personalized digital therapeutic designed to optimize their experience and health while on treatment AMSTERDAM, June 18, 2024 (GLOBE NEWSWIRE) -- Mika [...]
SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions
18/06/2024
MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte [...]
"I Have Insurance, Why Can't I Afford My Oral Anticancer Medications?" International Myeloma Foundation Highlights the Urgent Need for Cancer Drug Parity Act at Congressional Briefing
18/06/2024
The Successful Briefing Addressed Insurance Coverage for Oral Anticancer Medications WASHINGTON, June 18, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation-led Coalition to Improve Access to Cancer Care ( [...]
EssilorLuxottica and Diesel announce a ten-year licensing agreement
18/06/2024
ESSILORLUXOTTICA AND DIESEL ANNOUNCE A TEN-YEAR LICENSING AGREEMENT Charenton-le-Pont, France and Milan, Italy (18 June 2024) – EssilorLuxottica and Diesel announced today that they have signed an exclusive license [...]
EssilorLuxottica et Diesel annoncent un accord de licence de 10 ans
18/06/2024
ESSILORLUXOTTICA ET DIESEL ANNONCENT UN ACCORD DE LICENCE DE 10 ANS Charenton-le-Pont, France et Milan, Italie (18 juin 2024) – EssilorLuxottica et Diesel annoncent aujourd’hui la signature d’un accord de licence [...]
Canadian Red Cross and The Resilience Institute launch new program to promote readiness
18/06/2024
Roots for Resilience to engage with small, rural and Indigenous communities OTTAWA, June 18, 2024 (GLOBE NEWSWIRE) -- The Canadian Red Cross and The Resilience Institute are pleased to announce a new partnership that [...]
La Croix-Rouge canadienne et le Resilience Institute s’unissent pour lancer un programme de préparation destiné aux communautés rurales, autochtones ou moins peuplées : Roots for Resilience
18/06/2024
OTTAWA, 18 juin 2024 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne et le Resilience Institute ont le plaisir d’annoncer un nouveau partenariat visant à renforcer la résilience climatique des communautés rurales, [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2024
18/06/2024
Aggregated presentation by day and by market Purchases of own shares from June 10th to 14th 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2024
18/06/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 10 au 14 juin 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Actions to strengthen presence in North Africa : Congress & Surgeons trainings
18/06/2024
Press release Ecully, June 18, 2024 – 6 p.m. Presentation of the KAPHORN system to 200 surgeons at the SOTCOT Congress in Hammamet The Spineway Group, a specialist in innovative implants for the treatment of severe [...]
Actions de développement de la zone Moyen-Orient : congrès et formation chirurgiens
18/06/2024
Communiqué de presse Ecully, le 18 juin 2024 – 18h Présentation du système KAPHORN devant 200 chirurgiens au congrès de la SOTCOT à Hammamet Le groupe Spineway spécialiste des implants innovants pour le traitement des [...]
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
18/06/2024
Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT [...]
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
18/06/2024
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to [...]
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
18/06/2024
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been [...]
Acentra Health Names Heather Adamson as Senior Vice President of Marketing
18/06/2024
MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced [...]
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
18/06/2024
Pratteln, Switzerland, June 18, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, [...]
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
18/06/2024
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial [...]
Kriya Appoints Katherine Eade as Chief Legal Officer
18/06/2024
– Experienced biopharma executive to guide Kriya’s overarching legal strategy across corporate affairs, gene therapy R&D, and technology & manufacturing platforms – PALO ALTO, Calif., and RESEARCH TRIANGLE PARK [...]

Pages